section name header

Y-Site Injection Compatibility (1:1 Mixture)

Doxorubicin HCl liposomal

(Mfr: SEQ)(Conc: 0.4 mg/mLa)

I

Mannitol

(Mfr: BA)(Conc: 15%)

Remarks:

Partial loss of measured natural turbidity

Ref:

2087